We are thrilled to announce the official launch of AlpalifeBio's 2025 Academic Seminar Tour, which will bring our single-domain antibody (VHH) technology directly to leading universities and research institutes in Singapore, Taiwan, Japan, and Korea.

As a global pioneer in single-domain antibody discovery, AlpalifeBio is committed to advancing academic and scientific research by fostering collaboration with innovative minds across Asia. This public seminar series is designed to share the latest developments in VHH antibody generation, screening strategies, and real-world applications in immunotherapy, diagnostics, and synthetic biology.

What's in it for you?
To express our appreciation for the research community, we are offering a free single-domain antibody discovery service (valued at $12,000 USD) to participating labs, departments, or institutes. This includes alpaca immunization, phage display library construction, screening, and delivery of high-affinity VHH clones — with 100% intellectual property belonging to the recipient.

Why Join Us?

• Discover the full VHH antibody generation workflow

• Learn from real-world case studies across 1,000+ global clients

• Explore potential collaboration opportunities

• Receive free technical consultation and insights

• Access our no-cost discovery service, exclusively for tour participants

Who Should Attend?
This tour is open to university departments, research centers, and public or private institutes involved in:

• Immunology

• Oncology

• Molecular and structural biology

• Antibody engineering

• Drug discovery

• Biotechnology and more

Interested in Hosting a Seminar?
If you're located in Singapore, Taiwan, Japan, or Korea, and your university or research institute would like to host an on-site seminar, we'd love to connect.
Contact our team at [email protected] to secure a date or request more information.

Join us in exploring the exciting frontier of VHH antibody research — and let's build breakthroughs together.